Bremelanotide acetate - Generic Drug Details
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
What are the generic sources for bremelanotide acetate and what is the scope of freedom to operate?
Bremelanotide acetate
is the generic ingredient in one branded drug marketed by Palatin Technologies and is included in one NDA. There are four patents protecting this compound. Additional information is available in the individual branded drug profile pages.Bremelanotide acetate has seventy-nine patent family members in twenty-five countries.
One supplier is listed for this compound.
Summary for bremelanotide acetate
| International Patents: | 79 |
| US Patents: | 4 |
| Tradenames: | 1 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| DailyMed Link: | bremelanotide acetate at DailyMed |
US Patents and Regulatory Information for bremelanotide acetate
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Palatin Technologies | VYLEESI (AUTOINJECTOR) | bremelanotide acetate | SOLUTION;SUBCUTANEOUS | 210557-001 | Jun 21, 2019 | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | See Plans and Pricing | ||||
| Palatin Technologies | VYLEESI (AUTOINJECTOR) | bremelanotide acetate | SOLUTION;SUBCUTANEOUS | 210557-001 | Jun 21, 2019 | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | See Plans and Pricing | ||||
| Palatin Technologies | VYLEESI (AUTOINJECTOR) | bremelanotide acetate | SOLUTION;SUBCUTANEOUS | 210557-001 | Jun 21, 2019 | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | See Plans and Pricing | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for bremelanotide acetate
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Palatin Technologies | VYLEESI (AUTOINJECTOR) | bremelanotide acetate | SOLUTION;SUBCUTANEOUS | 210557-001 | Jun 21, 2019 | See Plans and Pricing | See Plans and Pricing |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for bremelanotide acetate
| Country | Patent Number | Title | Estimated Expiration |
|---|---|---|---|
| World Intellectual Property Organization (WIPO) | 2014071339 | See Plans and Pricing | |
| Australia | 2005249474 | See Plans and Pricing | |
| Ukraine | 118656 | ЗАСТОСУВАННЯ БРЕМЕЛАНОТИДУ У ЛІКУВАННІ ЖІНОЧОЇ СЕКСУАЛЬНОЇ ДИСФУНКЦІЇ (BREMELANOTIDE THERAPY FOR FEMALE SEXUAL DYSFUNCTION) | See Plans and Pricing |
| >Country | >Patent Number | >Title | >Estimated Expiration |
